[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75101]], camposKey:2199-1154 2022-06-01 Thromboembolism and Oral Contraceptives During the COVID-19 Pandemic: A Disproportionality Analysis Within the Spanish Pharmacovigilance Database211218, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59110]], camposKey:1744-6872 2016-01-01 CYP2C9 variants as a risk modifier of NSAID-related gastrointestinal bleeding: A case-control study6673, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56696]], camposKey:2213-8587 2016-01-01 Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population507516, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40833]], camposKey:1139-7357 2014-01-01 Knowledge upon the emergency contraceptive pill in Spain224228, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43718]], camposKey:2385-409X 2014-01-01 Knowledge upon the emergency contraceptive pill in Spain224228, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39775]], camposKey:0767-3981 2014-01-01 No differences between men and women in adverse drug reactions related to psychotropic drugs: a survey from France, Italy and Spain342348, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40045]], camposKey:0114-5916 2013-01-01 Adverse Events Associated with Emergency Contraceptive: Comparing the Results of a Follow Up Study with Those Coming from Spontaneous Reporting874874, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39]], camposKey:0031-6970 2013-01-01 Hip fracture rates and bisphosphonate consumption in Spain. An ecologic study559564, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40044]], camposKey:1742-7835 2013-01-01 Polypharmacy in highly dependent elderly patients: a series from Medora's electronical medical redords3030, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9199]], camposKey:1742-7835 2013-01-01 Weight Gain and Antipsychotics. A Case/non-case approach in vigibase88, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40046]], camposKey:1053-8569 2012-01-01 Dementia Mortality Rates and Cholinesterase Inhibitors Consumption in Castilla y Leon (Spain). An Ecologic Study7474, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9192]], camposKey:1742-7835 2012-01-01 Hypnotics and mortality: a systematic review of literature3535, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30]], camposKey:1742-7835 2012-01-01 MUSCULOSKELETAL SYMPTOMS ASSOCIATED WITH BISPHOSPHONATES. A RETROSPECTIVE FOLLOW-UP STUDY WITH INFORMATION FROM THE HEALTH IMPROVEMENT NETWORK (THIN)3536, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3372]], camposKey:1053-8569 2012-01-01 Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y León (Spain): Changes in the consumption pattern following the introduction of extended release methylphenidate435441, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9204]], camposKey:1053-8569 2012-01-01 Weight Gain Associated with Antipsychotics in a Naturalistic Setting: Icaro Study443443, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38]], camposKey:0264-410X 2011-01-01 Adverse events associated with pandemic influenza vaccines: Comparison of the results of a follow-up study with those coming from spontaneous reporting519522, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40048]], camposKey:1053-8569 2011-01-01 Carpal Tunnel Syndrome Associated with Bisphosphonates. A Population-Based Cohort Study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=16936]], camposKey:0210-5705 2011-01-01 Hepatitis colestásica por amoxicilina474477, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9195]], camposKey:0114-5916 2011-01-01 Hepatotoxicity Associated with Agomelatine: A Case/Non-Case Study969970, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=33]], camposKey:1742-7835 2011-01-01 Hip fracture rates and bisphosphonate consumption in Spain. An ecologic study3940, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9197]], camposKey:0114-5916 2011-01-01 Selective Serotonin Reuptake Inhibitors and Gastrointestinal Bleeding: A Meta-Analysis944945, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59111]], camposKey:0025-7753 2010-07-17 Metformin and vitamin B12 deficiency Metformina y deficiencia de vitamina B12286287, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54693]], camposKey:1470-269X 2010-01-01 Erratum: Prevalence of CYP2C9 polymorphisms in the south of Europe (Pharmacogenomics Journal (2009) DOI: 10.1038/tpj.2009.16))2430, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3377]], camposKey:0009-9236 2010-01-01 Response to rupatadine and heart rhythm disturbances3738, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59112]], camposKey:0210-5705 2009-12-01 Moxifloxacin and hepatic toxicity Moxifloxacino y toxicidad hepática719720, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59113]], camposKey:1575-0922 2009-05-01 Inappropriate secretion of vasopressin and valproate Secreción inadecuada de vasopresina y valproato00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59115]], camposKey:1575-0922 2009-01-01 Citalopram and inadequate secretion of vasopressin Citalopram y secreción inadecuada de vasopresina4748, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40]], camposKey:0009-9236 2009-01-01 Heart Rhythm Disturbances Associated With Rupatadine: A Case Series From the Spanish and Portuguese Pharmacovigilance Systems481484, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13482]], camposKey:0210-5705 2009-01-01 Hepatitis tóxica asociada al uso de medroxiprogesterona7273, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54694]], camposKey:1470-269X 2009-01-01 Prevalence of CYP2C9 polymorphisms in the south of Europe306310, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59114]], camposKey:0210-5705 2009-01-01 Toxic hepatitis associated with the use of medroxyprogesterone Hepatitis tóxica asociada al uso de medroxiprogesterona7273, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=34]], camposKey:1742-7835 2006-01-01 Hepatic damage related to non-steroidal anti-inflammatory drugs. A case/non case study3333, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56762]], camposKey:1742-7835 2006-01-01 The genetic basis of some adverse effects. The eudragene project2626][][][][][][][][][][][][][][][][][][][][][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@651d84, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@651042][][][][][][][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@413732]][][][][][][][]